Praxis Precision Medicines to Present at BofA Securities 2022 Healthcare Conference

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) announced participation in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11, 2022, at 5:00 p.m. ET. The event will be accessible via live webcast on the company's website, with a replay available for 90 days post-event. Praxis focuses on developing therapies for central nervous system disorders linked to neuronal excitation-inhibition imbalance, leveraging genetic insights. The company has multiple clinical-stage product candidates addressing psychiatric and movement disorders, and epilepsy.

BOSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside chat at BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 5:00 p.m. ET (2:00 p.m. PT).

The fireside chat will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 90 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across psychiatric disorders, movement disorders and epilepsy, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

When is the Praxis fireside chat at the BofA Securities 2022 Healthcare Conference?

The Praxis fireside chat is scheduled for May 11, 2022, at 5:00 p.m. ET.

How can I access the Praxis Precision Medicines fireside chat?

You can access the fireside chat via live webcast on the Investors + Media section of Praxis' website.

What is the focus of Praxis Precision Medicines?

Praxis focuses on developing therapies for central nervous system disorders related to neuronal excitation-inhibition imbalance.

How long will the replay of the fireside chat be available?

The replay of the fireside chat will be available on the Praxis website for 90 days after the event.

What product candidates does Praxis have in development?

Praxis has multiple clinical-stage product candidates for psychiatric disorders, movement disorders, and epilepsy.